TARAProtara Therapeutics, Inc.

$228M

Q4 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$40M

Net Income

-$39M

EPS (Diluted)

$-3.45

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$5M

Free Cash Flow

-$5M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$113M

Total Liabilities

$11M

Stockholders' Equity

$102M

Cash & Equivalents

$24M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$40M	-$10M	-284.1%
Net Income	-$39M	-$10M	-281.0%

TARA Q4 2022 Earnings — Protara Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena